/Hologic%2C%20Inc_%20logo%20outside%20building%20by-%20Tada%20Images%20via%20Shutterstock.jpg)
Marlborough, Massachusetts-based Hologic, Inc. (HOLX) develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health, focusing on early detection and treatment worldwide. With a market cap of $14.4 billion, the company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.
HOLX is all geared up for its fiscal Q3 2025 results after the market closes on Wednesday, Jul. 30. Before this event, analysts project this company to report an adjusted EPS of $1.05, down marginally from $1.06 in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in three of the last four quarters, while falling short in one quarter.